Chaim M. Hershko
#135,578
Most Influential Person Now
Chaim M. Hershko's AcademicInfluence.com Rankings
Chaim M. Hershkophilosophy Degrees
Philosophy
#6820
World Rank
#9924
Historical Rank
Logic
#3925
World Rank
#5155
Historical Rank
Chaim M. Hershkobiology Degrees
Biology
#9260
World Rank
#12445
Historical Rank
Biochemistry
#1395
World Rank
#1519
Historical Rank
Download Badge
Philosophy Biology
Why Is Chaim M. Hershko Influential?
(Suggest an Edit or Addition)Chaim M. Hershko's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Iron and infection. (1988) (601)
- Labile plasma iron in iron overload: redox activity and susceptibility to chelation. (2003) (452)
- Non‐Specific Serum Iron in Thalassaemia: an Abnormal Serum Iron Fraction of Potential Toxicity (1978) (412)
- Ferritin Synthesis in Inflammation: I. PATHOGENESIS OF IMPAIRED IRON RELEASE (1977) (267)
- Pathophysiology of Iron Overload a (1998) (267)
- The importance of non-transferrin bound iron in disorders of iron metabolism. (2000) (264)
- Role of deferiprone in chelation therapy for transfusional iron overload. (2003) (230)
- Variable hematologic presentation of autoimmune gastritis: age-related progression from iron deficiency to cobalamin depletion. (2006) (212)
- Ichthyosiform dermatosis with systemic lipidosis. (1974) (195)
- Action of chelators in iron-loaded cardiac cells: Accessibility to intracellular labile iron and functional consequences. (2006) (185)
- Results of long‐term deferiprone (L1) therapy: a report by the International Study Group on Oral Iron Chelators (1995) (166)
- Pathogenesis and management of iron toxicity in thalassemia (2010) (163)
- Suppressive Effect of Ferritin on in Vitro Lymphocyte Function (1979) (161)
- Desferrioxamine-chelatable iron, a component of serum non-transferrin-bound iron, used for assessing chelation therapy. (2001) (159)
- Iron Chelators for Thalassaemia (1998) (155)
- How I treat unexplained refractory iron deficiency anemia. (2014) (141)
- Role of iron in the potentiation of anthracycline cardiotoxicity: identification of heart cell mitochondria as a major site of iron-anthracycline interaction. (1996) (139)
- Role of autoimmune gastritis, Helicobacter pylori and celiac disease in refractory or unexplained iron deficiency anemia. (2005) (138)
- Heart cells in culture: a model of myocardial iron overload and chelation. (1985) (135)
- Iron-chelating therapy. (1988) (134)
- ICL670A: a new synthetic oral chelator: evaluation in hypertransfused rats with selective radioiron probes of hepatocellular and reticuloendothelial iron stores and in iron-loaded rat heart cells in culture. (2001) (133)
- High nontransferrin bound iron levels and heart disease in thalassemia major (2009) (132)
- The assessment of serum nontransferrin-bound iron in chelation therapy and iron supplementation. (2000) (130)
- Deferoxamine inhibition of malaria is independent of host iron status (1988) (127)
- Labile plasma iron (LPI) as an indicator of chelatable plasma redox activity in iron-overloaded beta-thalassemia/HbE patients treated with an oral chelator. (2004) (125)
- NON‐TRANSFERRIN PLASMA IRON (1987) (123)
- Storage Iron Kinetics (1973) (117)
- Storage iron kinetics. 3. Study of desferrioxamine action by selective radioiron labels of RE and parenchymal cells. (1973) (114)
- CURE OF APLASTIC ANÆMIA IN PAROXYSMAL NOCTURNAL HÆMOGLOBINURIA BY MARROW TRANSFUSION FROM IDENTICAL TWIN: FAILURE OF PERIPHERAL-LEUCOCYTE TRANSFUSION TO CORRECT MARROW APLASIA (1979) (114)
- Exploring the "iron shuttle" hypothesis in chelation therapy: effects of combined deferoxamine and deferiprone treatment in hypertransfused rats with labeled iron stores and in iron-loaded rat heart cells in culture. (2001) (106)
- Ferritin Synthesis in Inflammation: II. MECHANISM OF INCREASED FERRITIN SYNTHESIS (1981) (102)
- Storage Iron Kinetics: VI. THE EFFECT OF INFLAMMATION ON IRON EXCHANGE IN THE RAT (1974) (100)
- Control of disease by selective iron depletion: a novel therapeutic strategy utilizing iron chelators. (1994) (97)
- Systemic leishmaniasis mimicking malignant histiocytosis (1979) (85)
- Autoimmune gastritis (2020) (84)
- Serum ferritin in hematologic malignancies (1980) (84)
- Anthracycline toxicity is potentiated by iron and inhibited by deferoxamine: studies in rat heart cells in culture. (1993) (81)
- Iron overload in thalassaemia intermedia: reassessment of iron chelation strategies (2009) (81)
- Pathogenesis and management of iron deficiency anemia: emerging role of celiac disease, helicobacter pylori, and autoimmune gastritis. (2009) (79)
- Mechanism of in vivo iron chelation by pyridoxal isonicotinoyl hydrazone and other imino derivatives of pyridoxal. (1981) (77)
- Mechanism of iron toxicity and its possible role in red cell membrane damage. (1989) (77)
- Storage iron kinetics. II. The uptake of hemoglobin iron by hepatic parenchymal cells. (1972) (75)
- Mitochondrial respiratory enzymes are a major target of iron toxicity in rat heart cells. (1998) (75)
- Iron loading of cultured cardiac myocytes modifies sarcolemmal structure and increases lysosomal fragility. (1993) (75)
- Paraprotein interference with colorimetry of phosphate in serum of some patients with multiple myeloma. (1986) (73)
- A rapid and sensitive ELISA for serum ferritin employing a fluorogenic substrate. (1982) (69)
- Mechanism of Desferrioxamine‐Induced Iron Excretion in Thalassaemia (1979) (68)
- ABH Antigens and Bone Marrow Transplantation (1980) (64)
- Effect of iron loading on transmembrane potential, contraction, and automaticity of rat ventricular muscle cells in culture. (1989) (64)
- Reversal of cardiac complications in thalassemia major by long‐term intermittent daily intensive iron chelation (2003) (63)
- Quality of life and survival following intensive medical care. (1989) (60)
- Iron mobilization from myocardial cells by 3-hydroxypyridin-4-one chelators: studies in rat heart cells in culture. (1991) (60)
- Evaluation of iron status in patients on chronic hemodialysis: relative usefulness of bone marrow hemosiderin, serum ferritin, transferrin saturation, mean corpuscular volume and red cell protoporphyrin. (1983) (59)
- Phenolic ethylenediamine derivatives: a study of orally effective iron chelators. (1984) (59)
- The effect of chronic iron deficiency on some biochemical functions of the human hemopoietic tissue. (1970) (58)
- Regular Review: Iron and infection (1988) (57)
- Iron kinetics with emphasis on iron overload. (1973) (57)
- The effect of N-alkyl modification on the antimalarial activity of 3-hydroxypyridin-4-one oral iron chelators. (1991) (56)
- Storage iron regulation. (1977) (55)
- A hematologist's view of unexplained iron deficiency anemia in males: impact of Helicobacter pylori eradication. (2007) (55)
- Modification of iron uptake and lipid peroxidation by hypoxia, ascorbic acid, and alpha-tocopherol in iron-loaded rat myocardial cell cultures. (1987) (53)
- Nonspecific serum iron in thalassemia: Quantitation and chemical reactivity (1979) (52)
- The antimalarial effect of iron chelators: studies in animal models and in humans with mild falciparum malaria. (1992) (51)
- Regulation of intracellular iron metabolism in human erythroid precursors by internalized extracellular ferritin. (1999) (50)
- Cardioprotective effect of alpha-tocopherol, ascorbate, deferoxamine, and deferiprone: mitochondrial function in cultured, iron-loaded heart cells. (1999) (49)
- Iron chelators in medicine. (1992) (48)
- Prevention of anthracycline cardiotoxicity by iron chelation. (1996) (48)
- Iron Chelation Therapy (2002) (47)
- Mechanism of iron chelation in the hypertransfused rat: definition of two alternative pathways of iron mobilization. (1978) (45)
- Iron loading and its clinical implications (2007) (45)
- Incidence of hyperkalaemia induced by indomethacin in a hospital population. (1985) (45)
- Autologous bone marrow transplantation in patients with cancer. (1980) (44)
- Ability of the orally effective iron chelators dimethyl- and diethyl-hydroxypyrid-4-one and of deferoxamine to restore sarcolemmal thiolic enzyme activity in iron-loaded heart cells. (1994) (43)
- Diagnosis of iron deficiency anemia in a rural population of children. Relative usefulness of serum ferritin, red cell protoporphyrin, red cell indices, and transferrin saturation determinations. (1981) (43)
- QUALITY OF SLEEP IN THE MEDICAL DEPARTMENT (1992) (43)
- Iron, infection and immune function (1993) (43)
- Iron Metabolism, Iron Deficiency and Disorders of Haem Synthesis (2007) (43)
- Determinants of fecal and urinary iron excretion in desferrioxamine- treated rats (1978) (42)
- Progress in Iron Research (1994) (42)
- Syntheses of iron bis(pyridoxal isonicotinoylhydrazone)s and the in vivo iron-removal properties of some pyridoxal derivatives. (1983) (42)
- Iron Deficiency, Helicobacter Infection and Gastritis (2009) (41)
- Ironing out the mechanism of anemia in celiac disease (2008) (41)
- Iron overload and chelation (2005) (40)
- Purging iron from the heart (2004) (40)
- Ultrastructural pathology of iron-loaded rat myocardial cells in culture. (1987) (40)
- Prevalence and causes of anemia in elderly hospitalized patients. (1979) (39)
- Effects of combined chelation treatment with pyridoxal isonicotinoyl hydrazone analogs and deferoxamine in hypertransfused rats and in iron-loaded rat heart cells. (2003) (39)
- The anemia of achylia gastrica revisited. (2007) (39)
- Transfusion-related leukocytosis in critically ill patients* (2004) (38)
- Hepatosplenic peliosis after danazol and glucocorticoids for ITP. (1985) (37)
- A study of the chelating agent diethylenetriaminepentaacetic acid using selective radioiron probes of reticuloendothelial and parenchymal iron stores. (1975) (37)
- CONTROL OF STEROID‐RESISTANT AUTOIMMUNE HAEMOLYTIC ANAEMIA BY CYCLOSPORINE (1990) (37)
- Iron loading modifies the fatty acid composition of cultured rat myocardial cells and liposomal vesicles: effect of ascorbate and alpha-tocopherol on myocardial lipid peroxidation. (1989) (37)
- Prevalence and causes of anemia in the elderly. (1978) (35)
- THE FATE OF CIRCULATING HAEMOGLOBIN (1975) (35)
- The role of iron and iron chelators in anthracycline cardiotoxicity. (1993) (34)
- Severe reversible autoimmune haemolytic anaemia and thrombocytopenia associated with diclofenac therapy. (2009) (34)
- Objectives and Methods of Iron Chelation Therapy (2003) (32)
- Iron chelation therapy in patients with myelodysplastic syndromes: consensus conference guidelines. (2008) (31)
- Familial hemophagocytic lymphohistiocytosis (FHLH) in Israel. I. Description of 11 patients of Iranian—Iraqi origin and review of the literature (1984) (31)
- Serum ferritin in an elderly population. (1979) (30)
- Lead poisoning in a West Bank Arab Village. (1984) (30)
- Acute hemolytic anemia caused by severe hypophosphatemia in diabetic ketoacidosis. (1985) (30)
- Transient methimazole-induced bone marrow aplasia: in vitro evidence for a humoral mechanism of bone marrow suppression. (1983) (30)
- Mechanism of Iron Toxicity (2007) (30)
- The changing clinical spectrum of liver abscess: the Jerusalem experience. (1994) (30)
- Cerebrospinal fluid ferritin in malignant CNS involvement (1986) (29)
- Development of oral iron chelator L1 (1993) (29)
- Reversible central nervous system dysfunction in folate deficiency (1975) (29)
- Oral iron chelators: new opportunities and new dilemmas. (2006) (28)
- The iron-loaded gerbil model revisited: effects of deferoxamine and deferiprone treatment. (2002) (28)
- Increased formation of 5-phosphoriboxyl-1-pyrophosphate in red blood cells of some gouty patients. (1968) (27)
- Atrioventricular and sinoatrial block in thyrotoxic crisis. (1985) (27)
- Ferritin synthesis and Iron uptake in developing erythroid cells (1979) (26)
- Origin and fate of iron mobilized by the 3-hydroxypyridin-4-one oral chelators: studies in hypertransfused rats by selective radioiron probes of reticuloendothelial and hepatocellular iron stores. (1992) (26)
- Antimalarial effect of HBED and other phenolic and catecholic iron chelators (1989) (26)
- Oral iron chelating drugs: coming but not yet ready for clinical use (1988) (25)
- Iron depletion and blood lead levels in a population with endemic lead poisoning. (1984) (24)
- Vaccine efficacy and iron deficiency: an intertwined pair? (2021) (24)
- Familial hemophagocytic lymphohistiocytosis in Israel: II. Pathologic findings (1984) (24)
- Combined use of zinc protoporphyrin (ZPP), mean corpuscular volume and haemoglobin measurements for classifying microcytic RBC disorders in children and young adults. (1985) (24)
- Effect of age and duration of disease on the clinical manifestations of brucellosis. A study of 73 consecutive patients in Israel. (1993) (23)
- Acute Promyelocytic Leukaemia: A Report of Five Cases with a Comment on the Diagnostic Significance of Serum Vitamin B12 Determination (1972) (22)
- The Effect of Sex Difference on Iron Exchange in the Rat (1974) (22)
- Erythroid and myeloid maturation patterns related to progenitor assessment in the myelodysplastic syndromes (1987) (20)
- Mechanisms and prognostic value of cell kinetics in the myelodysplastic syndromes (1987) (20)
- Antimalarial effect of HBED and other phenolic and catecholic iron chelators. (1989) (20)
- Identification of community flour mills as the source of lead poisoning in West Bank Arabs. (1985) (20)
- Inhibition of calcium accumulation by the sarcoplasmic reticulum: a putative mechanism for the cardiotoxicity of adriamycin. (1997) (20)
- Determinants of fecal and urinary iron excretion in desferrioxamine-treated rats. (1978) (18)
- Destructive bone lesions in primary amyloidosis. (1986) (18)
- 3 Biological models for studying iron chelating drugs (1989) (18)
- Reversible cholestatic jaundice and hyperamylasaemia associated with captopril treatment. (1983) (18)
- Veno-occlusive disease and primary hepatic vein thrombosis in Israeli Arabs. (1981) (17)
- Deferoxamine-induced iron mobilization and redistribution of myocardial iron in cultured rat heart cells: studies of the chelatable iron pool by electron microscopy and Mössbauer spectroscopy. (1992) (17)
- The changing pattern of megaloblastic anemia: megaloblastic anemia in Israel. (1983) (16)
- Paraneoplastic hypercalcemia in endometrial carcinoma. (1989) (16)
- Disseminated intravascular coagulation and hypopotassemia associated with blast lung injury. (1986) (16)
- Increased Warfarin Sensitivity as an Early Manifestation of Occult Prostate Cancer with Chronic Disseminated Intravascular Coagulation (2001) (16)
- IRC011, a new synthetic chelator with selective interaction with catabolic red blood cell iron: evaluation in hypertransfused rats with hepatocellular and reticuloendothelial radioiron probes and in iron-loaded rat heart cells in culture. (1997) (16)
- Re-emergence of Lead Poisoning from Contaminated Flour in a West Bank Palestinian Village (2000) (15)
- Relapsing haemolytic anaemia of pregnancy with negative antiglobulin reaction. (2009) (15)
- Development and evaluation of the improved iron chelating agents EHPG, HBED and their dimethyl esters. (1984) (15)
- chelation Labile plasma iron in iron overload: redox activity and susceptibility to (2013) (14)
- Non-transferrin-bound serum iron (NTBI) in megaloblastic anemia: effect of vitamin B(12) treatment. (2004) (14)
- Desferrioxamine-chelatable iron (DCI), a component of serum non-transferrin-bound iron (NTBI) used for assessing iron chelation therapy. (2000) (14)
- Lead Poisoning by Contaminated Flour (1989) (13)
- Treating iron overload: the state of the art. (2005) (13)
- Storage iron kinetics. I. Measurement of the cellular distribution of 59 Fe in rat liver. (1972) (13)
- Morphological‐Biochemical Correlations in Rabbit Red Cell Precursors Synchronized by Actinomycin Administration (1969) (12)
- Spontaneous rupture of the spleen in amyloidosis. (1972) (12)
- Reduced incidence of hyperkalemia and azotemia in patients receiving sulindac compared with indomethacin. (1988) (11)
- Surface features and ultrastructure of isolated Kupffer cells as seen by scanning and transmission electron microscopy. (1978) (11)
- Changes in the natural history of invasive pulmonary aspergillosis in neutropenic leukemic patients. (1996) (11)
- Serum and erythrocyte folates in combined iron and folate deficiency. (1975) (11)
- Iron Mobilization in the Pregnant Rat (1976) (11)
- Cardioprotective effect of iron chelators. (2002) (11)
- Role of Iron Chelation Therapy in Thalassemia Major. (2002) (11)
- Effects of acute iron loading on contractility and spontaneous beating rate of cultured rat myocardial cells (1988) (10)
- Biological models for studying iron chelating drugs. (1989) (10)
- Gastropathic sideropenia. (2005) (10)
- Evaluation of iron‐chelating agents in an in vivo system: potential usefulness of EHPG, a powerful iron‐chelating drug (1982) (10)
- Decreased Treatment Failure Rates following Duodenal Release Ferrous Glycine Sulfate in Iron Deficiency Anemia Associated with Autoimmune Gastritis and Helicobacter pylori Gastritis (2007) (10)
- Causes of agranulocytosis in a hospital population: identification of dipyrone as an important causative agent. (1983) (10)
- Granulocyte Transfusion Therapy (1978) (10)
- Iron loading modifies beta-adrenergic responsiveness in cultured ventricular myocytes. (1991) (10)
- Rat heart cells in culture: a model of iron toxicity and chelation. (1993) (9)
- Iron overload in Asia. (2009) (9)
- Myelodysplastic syndromes: evolution of overt leukaemia by one or several steps of transformation (1987) (9)
- Reduced frequency of iron deficiency anaemia in sickle cell trait. (2009) (9)
- [Conclusions and recommendations of a WHO expert consultation meeting on iron supplementation for infants and young children in malaria endemic areas]. (2008) (9)
- Ribonucleic acid production and breakdown in synchronized erythroid cohorts from actinomycin-treated animals. (1971) (8)
- Serum Ferritin and Mean Corpuscular Volume Measurement in the Diagnosis of β-Thalassaemia minor and Iron Deficiency (1979) (8)
- An evaluation of the potential of HBED as an orally effective iron-chelating drug. (1990) (8)
- Deferasirox (Exjade®, ICL670): A Journey into Labile Iron Centers of Living Cardiomyocytes. (2005) (8)
- Treatment with captopril for peripheral ischaemia induced by ergotamine. (1984) (8)
- Pathophysiology of blood disorders (1979) (8)
- Defibrination following Echis colorata bite in man. (1970) (8)
- New Orally Effective Iron Chelators (1990) (8)
- Acute renal failure associated with non-fulminant type-A viral hepatitis. (1986) (8)
- Corticosteroid responsive immune thrombocytopenia in Hodgkin's disease. (1986) (8)
- Iron Toxicity and Chelating Therapy (1988) (7)
- Use of danazol in the management of chronic idiopathic thrombocytopenic purpura. (1985) (7)
- Prevalence and causes of anemia in children in Kiryat Shmoneh, Israel. (1970) (7)
- Increased leucocyte alkaline phosphatase and transcobalamin III in chronic myeloid leukaemia associated with lithium therapy. (2009) (7)
- Recurrent Neisseria meningitidis bacteremia. Association with deficiency of the eighth component of complement (C8) in a Sephardic Jewish family. (1984) (7)
- Serum ferritin in beta-thalassemia trait. (1978) (7)
- Assessment of iron deficiency (2018) (7)
- Causes of iron deficiency anemia in an adult inpatient population (1984) (7)
- Observations on the in vivo aging of red cells in the rat. (2009) (7)
- [Lead poisoning by contaminated flour: an unfinished story]. (2005) (7)
- oral chelator -thalassemia/HbE patients treated with an β activity in iron-overloaded Labile plasma iron (LPI) as an indicator of chelatable plasma redox (2013) (7)
- Chronic cutaneous polyarteritis nodosa simulating recurrent thrombophlebitis. (1985) (7)
- Androgen-responsive aplastic anemia in a dog. (1978) (7)
- The effect of packed cell volume, hemoglobin content and red cell count on whole blood viscosity. (1970) (7)
- [Ergot poisoning]. (1984) (6)
- The effect of electrical sleep on the viscosity of blood. (1970) (6)
- [The prevalence and causes of anemia in children in Kiryat Shmoneh]. (1971) (6)
- Transient Severe Eosinophilia Precipitating Massive Venous Thrombosis in a Patient with Hereditary Thrombophilia (2004) (6)
- Iron chelation in thalassemia: mechanism of desferrioxamine action. (1978) (6)
- Relapsing Coombs-negative haemolytic anaemia in pregnancy with haemolytic disease in the newborn. (1975) (6)
- Preparation, characterization and storage of human ferritin for use as a standard for the assay of serum ferritin (2008) (5)
- Hyperkalemia associated with sulindac therapy. (1986) (5)
- In vitro bioassay of erythropoietin using synchronized rabbit erythroid precursors. (1982) (5)
- Control of malaria by drug-mediated iron deprivation. (1994) (5)
- The Natural Course of Defibrination Syndrome Caused by Echis Colorata Venom in Man (1974) (5)
- Prevalence and causes of anemia in the elderly in Kiryat Shmoneh, Israel. (1979) (5)
- Surface morphology and ultrastructure of isolated hepatic Kupffer and endothelial cells. (1978) (5)
- Ferritin synthesis in developing erythroid precursor cells. (1978) (5)
- Deficiency of the Eighth Component of Complement. Evidence for Linkage of C8α‐γ Pattern with C8β Deficiency in Sera of Twelve Patients (1989) (4)
- Development of polycythemia vera in a patient with myeloid metaplasia and myelofibrosis. Report of a case with a comment on its significance in relation to prevailing views on myeloid metaplasia. (1971) (4)
- Halogenoderma of the Forearm Caused by 2‐Chlorodeoxyadenosine Treatment (1996) (4)
- Medical problems in Ethiopian refugees airlifted to Israel: experience in 131 patients admitted to a general hospital. (1986) (4)
- The haematologist as watchdog of community health by full blood count. (1995) (4)
- Protein- and hemoglobin-synthesizing ability of subcellular fractions isolated from erythroid cell cohorts synchronized by actinomycin D administration. (1971) (4)
- Regulating the master iron regulator hepcidin (2006) (3)
- Evolution of malignant lymphoma in agnogenic myeloid metaplasia. (1988) (3)
- The Inhibitory Effect of Vitamin E on Desferrioxamine-Induced Iron Excretion in Rats 1 (1976) (3)
- PLASMA NON TRANSFERRIN BOUND IRON- NTBI REVISITED Implications for systemic iron overload and in iv iron supplementation. (2021) (3)
- Budd-Chiari syndrome in childhood: a study of two patients. (1971) (3)
- labile iron and functional consequences Action of chelators in iron-loaded cardiac cells : accessibility to intracellular (2006) (3)
- 10 Iron and infection (1989) (3)
- Principles of iron chelating therapy. (1990) (3)
- Identification of thiolic sarcolemmal proteins as a primary target of iron toxicity in cultured heart cells. (1994) (3)
- Clinical Use of Iron Chelators (2012) (3)
- Iron chelation. (1990) (2)
- Multivariate analysis of prognostic factors in chronic lymphocytic leukemia. (1985) (2)
- How I Treat How I treat unexplained refractory iron de fi ciency anemia (2013) (2)
- Effect of iron deficiency on transplantable murine plasmacytoma. (1981) (2)
- Iron loading and chelation as studied in a heart cell culture system. (1987) (2)
- Reply to commentary: Hepcidin mimetics from microorganisms? A possible explanation for the effect of Helicobacter pylori on iron homeostasis (2007) (2)
- Bone marrow transplantation in aplastic anemia and leukemia. (1980) (2)
- Time-related increase in leucocyte yields by continuous-flow centrifugation (CFC) leukopheresis. (2009) (2)
- The effect of erythropoietin and erythroid hyperplasia on the response of rabbit bone marrow to actinomycin D. (1971) (2)
- Is Iron-Chelation Therapy Useful in Persons with Myelodysplastic Syndrome Receive? (2011) (2)
- Increased Non-Transferrin-Bound Serum Iron in Megaloblastic Anaemia (2002) (2)
- Infective endocarditis due toStenotrophomonas (Xanthomonas) maltophilia (1998) (2)
- Serum ferritin and mean corpuscular volume measurement in the diagnosis of beta-thalassaemia minor and iron deficiency. (1979) (2)
- Reply to: Prophylactic use of deferiprone (L1) and MRI T2* or T2 for preventing heart disease in thalassaemia (2004) (2)
- Chasing iron deficiency (2003) (2)
- Granulocyte transfusion therapy: a clinical trial in patients with acute leukemia and sepsis. (1978) (1)
- Trading muscle iron for erythropoiesis at high altitude (2007) (1)
- Traumatic hemolysis after aortofemoral bypass. A study of 25 cases. (1977) (1)
- Mechanism of in vivo iron chelation (1982) (1)
- Cryopathic haemolytic anaemia associated wtih uterus myomatosus. (1980) (1)
- The clinical relevance of detectable plasma iron species in iron overload states and subsequent to intravenous iron‐carbohydrate administration (2022) (1)
- Correlation between iron uptake, lipid peroxidation and action potential duration in cultured heart cells (1987) (1)
- Hepatic vein thrombosis in children in the Near East. (1972) (1)
- Cell-cycle regulation by iron depletion (2007) (1)
- Anemia among Druze children in the Golan Heights. (1980) (1)
- C5 Deficiency in a White Family-Reply (1985) (1)
- The Hidden Face of Pernicious Anemia: Age-Related Progression of Autoimmune Gastritis from Iron Deficiency to Cobalamin Depletion. (2005) (0)
- Plasma nontransferrin bound iron–nontransferrin bound iron revisited: Implications for systemic iron overload and in iv iron supplementation (2021) (0)
- IRON AND INFECTION 55 CLINICAL STUDIES IN IRON DEFICIENCY AND OVERLOAD (2006) (0)
- Iron loading modifies sarcolemmal fatty acid composition of cultured heart cells (1990) (0)
- 25 The basics: iron overload (2009) (0)
- Effects of iron, ascorbate, and $alpha;-tocopherol on liposomal lipid peroxidation*1 (1988) (0)
- Iron overload in cultured myocardial cels (1986) (0)
- [Remission of severe aplastic anemia following antithymocyte globulin therapy]. (1986) (0)
- [Unusual cases of fever in West Bank Arabs]. (1984) (0)
- I10 Refractory iron deficiency anemia (2007) (0)
- Contents, Vol. 48, 1988 (1975) (0)
- Effects of Combined Chelation Treatment with Pyridoxal Isonicotinoyl Hydrazone (PIH) Analogs and Deferoxamine in Hypertransfused Rats and in Iron-Loaded Rat Heart Cells Running Head: Combined PIH analog and DFO Chelation Treatment Heading: Red Cells (2017) (0)
- [Lead poisoning]. (1983) (0)
- Iron, bone, and marrow. (2010) (0)
- About the cover illustration Heart cells in tissue culture (1993) (0)
- Pathogenesis and management of iron overload in thalassemia. (1975) (0)
- Interleukin-6 induces hepcidin expression through STAT3. Commentary (2006) (0)
- False‐negative D‐dimer test in a patient with disseminated lntravascular coagulation (1995) (0)
- [Favorable response to Metrulen in Von Willebrand's disease (type III)]. (1984) (0)
- ParaproteinInterferencewithColorimetryof Phosphatein Serum of Some Patientswith MultipleMyeloma (2004) (0)
- New Directions in Iron Chelating Therapy (1996) (0)
- Contents Vol. 112, 2004 (2004) (0)
- Iron chelation. (1989) (0)
- Serum Ferritin in β - Thalassemia Trait (1979) (0)
- Novel approaches in the treatment of iron overload (2005) (0)
- Pathophysiology and management of transfusional iron overload (1998) (0)
- THE VALUE AND PRICE OF MEN’S ADDICTION TO IRON On chronic iron deficiency and novel treatments relevant to corona days (2020) (0)
- Resolving the Riddle of Obscure Iron Deficiency Anemia. (2007) (0)
- Renal salvage of haemoglobin iron. (2009) (0)
- Therapeutic Potential of Iron Chelating Therapy: Modification of Disease by Iron Depletion (1994) (0)
- Subject Index Vol. 112, 2004 (2004) (0)
- Hemochromatosis redefined. (2022) (0)
- Pyridoxyl hydrazone derivative and pharmaceyutical composition containing it (1988) (0)
- Blood 7 O C T O B E R 2 0 1 0 I V O L U M E 1 1 6 , N U M B E R 1 4 (0)
- [Neisseria infections in hereditary complement deficiency]. (1988) (0)
- [Lead poisoning in West Bank Arabs caused by contaminated flour]. (1986) (0)
- Deficiency of the eighth component of complement. Evidence for linkage of C8 alpha-gamma pattern with C8 beta deficiency in sera of twelve patients. (1989) (0)
- SYNTHESES OF IRON(II) BIS(PYRIDOXAL ISONICOTINOYLHYDRAZONE)S AND THE IN VIVO IRON-REMOVAL PROPERTIES OF SOME PYRIDOXAL DERIVATIVES (1983) (0)
- Cell kinetics in leukemia and preleukemia. (1987) (0)
- [Hemochromatosis and iron chelating therapy]. (1986) (0)
- Pathogenesis and Management of Iron Overload in MDS (2011) (0)
- Pyridoxyl-hydrazone derivatives and to pharmaceutical compounds containing these (1988) (0)
- Iron and high living (2005) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Chaim M. Hershko?
Chaim M. Hershko is affiliated with the following schools:
